Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial

INTRODUCTION: Helicobacter pylori (H. pylori) is the most well-known risk factor for gastric cancer. At present, H. pylori shows varying levels of resistance to different treatments, leading to a lower rate of H. pylori eradication. The aim of this study is to evaluate the efficacy of polaprezinc-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dingkun, Sun, Zhen, Li, Tingyuan, Tan, Qinwen, Sun, Yue, Chen, Tingting, Liu, Yujing, Li, Jun, Jiang, Haidong, Yuan, Zhiqiang, Zhao, Yuqian, Chen, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674085/
https://www.ncbi.nlm.nih.gov/pubmed/33203625
http://dx.doi.org/10.1136/bmjopen-2020-037182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674085/
https://www.ncbi.nlm.nih.gov/pubmed/33203625
http://dx.doi.org/10.1136/bmjopen-2020-037182

Ejemplares similares